Table 1: Demographic data and IL-17 and IL-22 levels in the cerebrospinal fluid (CSF) and plasma of Guillain-Barré syndrome (GBS) patients and healthy controls (HC).

GBS (n = 22)HC (n = 18)

Female/male8/147/11
Age41.91 ± 13.1639.11 ± 11.18
White blood cells in CSF (per μL)1.32 ± 1.211.06 ± 0.94
Total protein level in CSF (mg/dL)71.56 ± 30.79*52.01 ± 12.81
Albumin level in CSF (mg/dL)49.58 ± 25.33**30.27 ± 11.71
Albumin level in plasma (g/L)41.55 ± 12.5643.67 ± 14.66
Qalb × 1001.24 ± 0.60*0.79 ± 0.45
IL-17 concentration in CSF (pg/mL)24.77 ± 7.45*18.70 ± 8.72
IL-17 level in plasma (pg/mL)17.39 ± 4.87*13.35 ± 4.54
IL-22 concentration in CSF (pg/mL)25.38 ± 12.35***8.19 ± 2.50
IL-22 level in plasma (pg/mL)96.40 ± 52.28*63.01 ± 27.22

Data are expressed as mean ± SD, student's t-test. *: Statistically significant in comparison with HC, *P < 0.05, **P < 0.01, ***P < 0.001.
Qalb = CSF albumin/plasma albumin.